>International Federation of Infection Control (IFIC).
The goal of IFIC is to minimise the risk of infection within the healthcare setting worldwide through development of a network of infection control organisations for communication, consensus building, education and sharing expertise.
>European Surveillance of Antibiotic Resistance (ESAR)
A Study of the European Society of Biomodulation and Chemotherapy
Surveillance of antimicrobial resistance is essential for good healthcare resource utilisation. It helps to ensure the best use of antimicrobials and infection control practices, optimum clinical outcomes and help in new anti-infective strategies. A study is proposed to set up a European wide programme of surveillance on incidence and mechanisms of resistance using sentinel laboratories and standardised methodology.
>European Society of Clinical Microbiology & Infectious Diseases (ESCMID)
Established in 1983, ESCMID has developed into the world’s largest clinical microbiology and infectious diseases society. It also established the European Committee on Infection Control, EUCIC and has initiated several important collaborative initiatives.
>European Drug Utilization Research Group (Euro DURG)
Euro DURG is an official scientific non-profit organization. The Euro DURG has as its mission the promotion of drug utilisation research as a means of improving use of drugs by providing an international forum for communication and cooperation between people interested in drug utilisation research.
>Center for Adaptation Genetics and Drug Resistance.
Established in 1992, the overall goal of the Center is to investigate common biologic themes in the adaptation responses of eukaryotic and prokaryotic cells to environmental signals and hazards.
>APUA - Alliance for the Prudent Use of Antibiotics.
The APUA alliance was formed in 1981 and has affiliated chapters in over 66 developed and developing countries. Its mission being to preserve the effectiveness of antimicrobial drugs by undertaking research and advocacy programs.
>Global Antibiotic Resistance Partnership (GARP)
Develops actionable policy proposals on antibiotic resistance for low and middle income countries and promote greater awareness of national policymakers about the need to be part of global efforts to control antibiotic resistance
An independent global network for concerted action on antibiotic resistance. ReAct aims for profound change in awareness and action to manage the interacting social, political, ecological and technical forces that drive the rising rate of resistant human and animal infection and the rapid spread of resistance within and between communities and countries.
>World Alliance Against Antibiotic Resistance
World Alliance Against Antibiotic Resistance ( WAAR) The alliance developed a statement representing a strong consensus between the different professionals, on actions and measures to tackle antibiotic resistance.
24.08.2012. Chennai Declaration A joint meeting of medical societies in India was organized as a pre-conference symposium of the 2nd annual conference of the Clinical Infectious Disease Society (CIDSCON 2012) at Chennai. The symposium examined how medical societies in India can work together to tackle the issue of resistance from the Indian perspective.
>Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator
CARB-X, - invests in drug and diagnostic discovery and development projects to tackle antibiotic resistance. CARB-X supports biotech companies and research teams to accelerate the development of new life-saving antibacterials and diagnostics.
The Infection Control Africa Network (ICAN) exists to promote and facilitate the establishment of infection control programmes, achievement and maintenance of infection reduction, including healthcare associate infections, and promote antimicrobial stewardship activities through education by working with infection prevention structures in Africa and other International health related associations.
ICAN Member Countries
>CAESAR - Central Asian and Eastern European Surveillance of AMR
CAESAR is part of the Global initiative GLASS, the Global Antimicrobial Resistance Surveillance System; it is a network gathering together countries which are not part of the AMR surveillance network EARS-Net of the European Commission. The CAESAR network aims to undertake surveys, contribute reports of antibiotic resistance and draw up national action plans by developing national AMR surveillance systems based on similar data standards and methodology as used by the EARS-Net. The first annual CAESAR report was published in October 2015.
>JPIAMR - Joint Programme Initiative on AMR
27 Member states have joined forces to address the fragmentation of research activities across Europe by coordinating the research and thus avoid duplication. The Programme gathers together industry, public health bodies and academic bodies from various scientific disciplines to share experience and resources.
>One Health Global Network
The One Health Global Network, a network of networks facilitates coordination and provides linkages; offering a global geographic dimension and optimal complementarity between initiatives. One Health aims to improve health and well-being through the prevention of risks and the mitigation of effects of crises that originate at the interface between humans, animals and their various environments
https://beam-alliance.eu. A group of European biotechs, innovating in antimicrobial resistance (AMR) working to improving the regulatory, investment, and commercial environments in Europe for research, development and market viability of new products to combat AMR.
>Health Action International (HAI) http://haiweb.org/
HAI was founded by a group of medicine policy experts in 1981 to counter the rapidly increasing influence of the pharmaceutical industry. In the 1990s, HAI gained notoriety for exposing the harmful impact of mark-ups on medicine availability. In 2001, it led a successful campaign to prevent direct-to-consumer advertising of prescription-only medicines in Europe. HAI has grown into a vast network of organisations, academics, healthcare professionals and policymakers in more than 70 countries worldwide currently focused on current global health priorities, like communicable and infectious diseases, neglected tropical diseases and antibiotic resistance.
HealthforAnimals is a non-profit, non-governmental organization representing companies and industry associations from both developed and developing countries. HealthforAnimals represents the animal health sector: manufacturers of veterinary pharmaceuticals, vaccines and other animal health products throughout the world, as well as the associations that represent companies at national and regional levels (referred to as Members).
>GAFFI -Global Action Fund for Fungal Infections . http://www.gaffi.org
Based in Geneva, GAFFI aims to improve patient care, treatment and diagnostics of fungal infections. Fungal Infections are neglected diseases worldwide.It is estimated that over 300 million people a year throughout the world suffer from a serious fungal infection, a much neglected disease.
>KAW - The Keep Antibiotics Working Coalition
The Keep Antibiotics Working (KAW) Coalition fights against the spread of antibiotic-resistant superbugs resulting from the overuse of antibiotics on farms. It is a coalition of advocacy groups working together to stop the overuse of antibiotics in livestock and feed.
The C.diff Foundation was founded in 2012 with a mission of raising C.diff awareness worldwide by educating and advocating for C. difficile infection prevention, treatments, support and environmental safety worldwide to end the suffering from this infection and help save lives.